Advertisement
For patients with severe community-acquired pneumonia and high initial inflammatory response

Methylprednisolone Use Cuts Treatment Failure in Pneumonia

0
Findings for patients with severe community-acquired pneumonia, high inflammatory response
A novel oral substrate reduction therapy

Eliglustat Safely Reverses Manifestations of Gaucher’s

0
Significant improvement in spleen volume for untreated adults with type 1 disease
In a new study

Fondaparinux Found to Effectively Treat NSTEMI

0
Swedish researchers find fondaparinux is effective, and reduces bleeding risk versus heparin
For individuals with dementia living in nursing homes

Antipsychotic Rx Often Relates to Non-Approved Indications

0
Major categories of reasons for medication use are behavioral, psychiatric, emotional states, cognition
Fear of corporate defamation lawsuits should not prevent medical journals from investigating corporate products

Medical Journals Should Not Be Swayed by Fear of Libel Lawsuits

0
Fear of corporate defamation lawsuits should not prevent examination of corporate products
New research supports previous findings that erythromycin can increase the risk of infantile hypertrophic pyloric stenosis (IHPS). The research also indicates that azithromycin is associated with a higher risk of IHPS when given to infants under 6 weeks old. The findings were published online Feb. 16 in the Pediatrics.

Certain Macrolides Linked With Higher Risk of Pyloric Stenosis

0
Risk, though small, appears highest when medications given in first six weeks
Women and men below age 70 who are treated for osteoporosis have an excess mortality risk

Osteoporosis-Treated Adults Have Elevated Risk of Mortality

0
Residual life expectancy for 50- and 75-year-old man starting treatment estimated at 18.2 and 7.5 years
Women who use hormone therapy after menopause -- even for just a few years -- may have an increased risk of ovarian cancer

HRT Use, Even Short Term, Tied to Higher Risk of Ovarian CA

0
Overall increase is small, though, adding one cancer per 1,000 women treated
Patients often prefer physicians with formal attire and white coats

Patients Tend to Prefer Formal Physician Attire

0
Patient preferences influenced by age, geographic location, context of care
The kinase inhibitor Lenvima (lenvatinib) has been approved by the U.S. Food and Drug Administration to treat differentiated thyroid cancer that has progressed despite radioactive iodine therapy

FDA Approves Lenvima for Type of Thyroid Cancer

0
To treat differentiated thyroid cancer that has progressed despite radioactive iodine therapy